Skip to content

Ginkgo Bioworks

US · DNA #3438 by market cap
7.46 -0.74 -9.02%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:58

Price chart

Pre-market 8.14 -0.73%
After-hours 7.55 +1.21%
Overnight 8.11 -1.10%
14.986.537.462026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on DNA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is +1.3% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 14.1% of float.
  • Analyst tilt is Sell.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -22.37%
1M -24.34%
3M +7.18%
6M -3.37%
YTD -10.23%
1Y -4.60%
3Y -87.81%
5Y -98.61%

Key statistics

Price & volume

Prev close
8.20
Open
7.93
Day range
7.38 - 8.29
Avg price
7.67
Volume
2.51M
Turnover
19.26M
Amplitude
11.10%
52-week range
5.37 - 18.22

Valuation

P/E
-1.32
P/E (TTM)
-1.79
P/B
1.23
EPS
-5.64
Net profit
-365.61M
Net assets
392.65M

Share structure

Market cap
483.59M
Float cap
389.24M
Shares out
64.83M
Float shares
52.18M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 16% of range
5.37 18.22

59.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+5.84M net over the window

Short interest

Shares short
9.49M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Ginkgo Bioworks (DNA)?

Ginkgo Bioworks last traded at 7.46. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Ginkgo Bioworks's market cap?

About 483.59M.

What is the P/E ratio of Ginkgo Bioworks?

The trailing twelve-month P/E is -1.79. The Valuation tab shows it against the stock's own five-year range.

Does Ginkgo Bioworks pay a dividend?

Ginkgo Bioworks does not currently pay a regular dividend.

Is Ginkgo Bioworks a buy according to analysts?

The consensus of 1 analysts is a Sell rating, with an average 12-month price target of 5.00, which implies 33.0% downside from the current price. This is not investment advice.

What is Ginkgo Bioworks's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Ginkgo Bioworks a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:58:34 · For reference only, not investment advice and not tailored to your situation.

Ginkgo Bioworks discussion 0 comments

Add a comment